1,3-dipropyl-8-cyclopentylxanthine has been researched along with myelin oligodendrocyte glycoprotein (35-55) in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Augusto, E; Chen, JF; He, JC; Huang, QY; Li, F; Li, ZZ; Wang, XT; Wang, ZW; Yao, SQ; Zheng, RY | 1 |
1 other study(ies) available for 1,3-dipropyl-8-cyclopentylxanthine and myelin oligodendrocyte glycoprotein (35-55)
| Article | Year |
|---|---|
Genetic inactivation of the adenosine A(2A) receptor exacerbates brain damage in mice with experimental autoimmune encephalomyelitis.
Topics: Adenosine A1 Receptor Antagonists; Animals; Astrocytes; Axons; Brain Injuries; Cell Proliferation; Cells, Cultured; Cerebral Cortex; Cytokines; Demyelinating Diseases; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Enzyme-Linked Immunosorbent Assay; Female; Filtration; Flow Cytometry; Freund's Adjuvant; Gene Expression Regulation; Mice; Mice, Inbred C57BL; Mice, Knockout; Microglia; Myelin-Oligodendrocyte Glycoprotein; Peptide Fragments; Protein Binding; Receptor, Adenosine A2A; RNA, Messenger; Spinal Cord; Spleen; Statistics, Nonparametric; Tritium; Xanthines | 2012 |